BioMarin Pharmaceuticals Shares Are Trading Lower After Truist Securities Lowered Its Price Target on the Stock From $140 to $118.
BioMarin Pharmaceuticals Shares Are Trading Lower After Truist Securities Lowered Its Price Target on the Stock From $140 to $118.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.